Home » Topics » BioWorld

BioWorld
RSS

IMCLONE EXPLANDS TRIALS OF MELANOMA DRUG

March 24, 1992

AIDS THERAPY TRIALS 'SUGGEST' PROMISE

March 24, 1992

CHIRON T0 USE LIDAK SCID MICE IN HIV TEST

March 24, 1992

MABS MAKER FILES TO SELL 2.3 MILLION SHARES

March 23, 1992

DEPRENYL STOCK STAGES A REBOUND

March 23, 1992

ORAL DELIVERY DEVELOPER RAISES $17.8M

March 23, 1992

GENZYME HORMONE DESIGNATED ORPHAN

March 23, 1992

OVERFED IPO MARKET CATCHES ITS BREATH

March 23, 1992

THREE PATENTS COVER NEUROGEN TECHNOLOGY

March 23, 1992

APPOINTMENTS AND ADVANCEMENTS

March 23, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...